The University of Chicago Header Logo

Connection

Thomas Gajewski to Carcinoma, Basal Cell

Back to Details
This is a "connection" page, showing publications Thomas Gajewski has written about Carcinoma, Basal Cell.
Thomas Gajewski
Connection Strength
0.195
Carcinoma, Basal Cell
  1. Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas. J Immunother Cancer. 2023 06; 11(6).
    View in: PubMed
    Score: 0.195
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.